By Reuters Staff
1 Min Read
NEW DELHI (Reuters) - India’s drugs regulator is likely to approve administering two doses of the AstraZeneca/Oxford vaccine and another locally-developed one by Bharat Biotech, each four weeks apart, two sources with knowledge of the matter told Reuters on Saturday.
Experts at India’s Central Drugs Standards Control Organisation (CDSCO) have already approved the vaccines and a final decision is expected to be announced by the agency’s chief at a news conference scheduled on Sunday.
Calls to CDSCO were unanswered outside regular business hours.
Reporting by Shilpa Jamkhandikar and Krishna N. Das; editing by David Evans
Expert Panel Clears Bharat Biotech’s Covaxin Amid UK Virus Strain: What You Need to Know
FOLLOW US ON:
An expert panel of India s central drug authority has recommended granting permission for restricted use of Bharat Biotech-developed indigenous COVID-19 vaccine Covaxin in emergency situation, especially in the context of infection by mutant strains, officials said on Saturday.
The recommendation for Bharat Biotech s vaccine came a day after the panel cleared the Serum Institute of India s emergency use authorisation application for the Oxford-AstraZeneca vaccine Covishield, paving the way for the roll-out of COVID-19 shots in the country in the next few days.
Delhi has completed a full dry run as India prepares to deliver 50million doses of the Oxford vaccine that it has manufactured and stockpiled.
Experts at the country s drugs regulator have recommended for emergency use two coronavirus vaccines, one developed by AstraZeneca and Oxford University and the other backed by a state-run institute, the government said today.
SII, the world s biggest producer of vaccines, has already stockpiled about 50million doses of the AstraZeneca/Oxford shot, which will be sold to the government at about 250 rupees (£2.50) per dose and 1,000 rupees on the private market.
India s government plans to inoculate 300million people in total in the first phase of the vaccination programme, which will include healthcare and front-line workers, police and military troops and over-50s with underlying medical conditions.
Man applies finishing touches to graffiti representing a vaccine in Kolkata
NEW DELHI (Reuters) – Experts at India’s drugs regulator have recommended for emergency use two coronavirus vaccines, one developed by AstraZeneca and Oxford University and the other backed by a state-run institute, the government said on Saturday.
A government minister said earlier the AstraZeneca/Oxford vaccine had been given the green light on Friday, paving the way for a huge immunisation campaign in the world’s second most populous country.
The government said the final decision on the two vaccines would be made by the Central Drugs Standards Control Organisation’s (CDSCO) chief, who has called a news conference on Sunday. The process for the final approval is expected to be a formality given the urgency for a vaccine in the country with the highest number of COVID-19 infections in the world after the United States.
Home >News >India >Covid-19 vaccination: Govt to provide free vaccines to 1 cr healthcare, 2 cr frontline workers, in 1st phase
Covid-19 vaccination: Govt to provide free vaccines to 1 cr healthcare, 2 cr frontline workers, in 1st phase
A health worker opens the deep freezer containing the vaccine during the dry run at a Primary Health Centre in Jaipur on Saturday. Himanshu Vyas/ ht
(HT PRINT)
Share Via
Read Full Story
New Delhi: The government will provide free vaccines to most prioritised beneficiaries inlcuding1 crore healthcare and 2 crore frontline workers, in the first phase of covid-19 vaccination that is expected to begin soon, union health minister Harsh Vardhan said on Saturday.